By Counterforce Health Team in Kanuma (sebelipase alfa) —

Myths vs. Facts: Getting Kanuma (Sebelipase Alfa) Covered by UnitedHealthcare in Georgia

Quick Answer: Getting Kanuma Covered by UnitedHealthcare in Georgia

UnitedHealthcare requires prior authorization for Kanuma (sebelipase alfa) with no step therapy requirements. Key requirements include confirmed LAL-D diagnosis via enzyme testing or LIPA gene variants, plus clinical evidence like hepatosplenomegaly or abnormal liver function. If denied, you have 60 days to file an external review with the Georgia Department of Insurance. Start today: Gather your LAL enzyme test results and submit your PA request through the UnitedHealthcare provider portal.

Table of Contents

Why Myths About Kanuma Coverage Persist

Getting Kanuma (sebelipase alfa) approved by UnitedHealthcare can feel overwhelming, especially when dealing with a rare disease like lysosomal acid lipase deficiency (LAL-D). Misinformation spreads quickly in patient communities, often based on outdated policies or experiences with other insurers.

The reality? UnitedHealthcare's coverage process for Kanuma is actually more straightforward than many patients realize—once you understand the real requirements and avoid common pitfalls.

Counterforce Health specializes in turning insurance denials into successful appeals by analyzing the specific denial reasons and crafting evidence-backed responses that align with each payer's own rules. Their platform helps patients and clinicians navigate complex prior authorization requirements for specialty medications like Kanuma.

Common Myths vs. Facts

Myth 1: "If my doctor prescribes Kanuma, UnitedHealthcare has to cover it"

Fact: Prior authorization is required for all Kanuma prescriptions. UnitedHealthcare's OptumRx division manages specialty drug approvals and requires specific documentation before coverage begins. Your doctor must submit a PA request with diagnostic evidence and clinical justification.

Myth 2: "I need to try cheaper medications first (step therapy)"

Fact: UnitedHealthcare does not require step therapy for Kanuma in LAL-D treatment. Unlike many other conditions, there are no approved alternative enzyme replacement therapies for LAL-D. The focus is on confirming your diagnosis and medical necessity, not trying failed alternatives.

Myth 3: "Denials are final—there's no point in appealing"

Fact: UnitedHealthcare's appeal success rate is 85.2% for overturned denials in 2023. Most initial denials result from incomplete documentation rather than true ineligibility. Georgia's external review process provides an additional layer of independent physician review.

Myth 4: "Generic versions work just as well"

Fact: There are no generic versions of Kanuma. Sebelipase alfa is a recombinant enzyme replacement therapy with no biosimilar alternatives currently approved by the FDA. Any "alternatives" suggested by insurers would be supportive treatments, not enzyme replacement.

Myth 5: "Prior authorization takes months to process"

Fact: UnitedHealthcare's standard PA turnaround is 72 hours for routine requests and 24 hours for urgent cases. If they don't respond within these timeframes, the request is automatically approved under their policy.

Myth 6: "I can't get coverage if I live in Georgia"

Fact: Georgia residents have the same access to UnitedHealthcare coverage as other states, plus additional protection through Georgia's external review process. The Georgia Department of Insurance provides free independent review of denied claims within 60 days of internal appeal denial.

Myth 7: "The medication is too expensive for any insurance to cover"

Fact: While Kanuma costs approximately $0.89M–$4.9M annually depending on weight and dosing, UnitedHealthcare and other major insurers routinely cover it when medical necessity criteria are met. The high cost actually strengthens the case for coverage since no alternatives exist.

Myth 8: "I need a specialist referral before starting the PA process"

Fact: While UnitedHealthcare recommends involvement of hepatologists, cardiologists, or metabolic specialists, the PA can be initiated by your primary care physician if they have the necessary diagnostic documentation and clinical expertise.

What Actually Influences Approval

Understanding UnitedHealthcare's actual approval criteria helps you focus on what matters:

Required Documentation

Requirement What UnitedHealthcare Needs Where to Get It
LAL Enzyme Test Activity <1.5 nmol/h/mL on dried blood spot Labcorp, Mayo Clinic Labs, or Quest
Clinical Evidence Hepatosplenomaly, abnormal ALT/AST, lipid abnormalities Medical records, imaging, lab reports
LIPA Gene Testing Pathogenic variants (if enzyme testing inconclusive) Genetic counselor or specialized lab
Dosing Justification FDA label-compliant weight-based dosing Prescription with patient weight/BSA

Medical Necessity Criteria

UnitedHealthcare approves Kanuma when you meet these evidence-based criteria:

  • Confirmed LAL-D diagnosis through enzyme activity testing or genetic confirmation
  • Clinical manifestations including hepatomegaly, elevated liver enzymes, or dyslipidemia
  • Age-appropriate dosing following FDA labeling (1 mg/kg every 2 weeks for most patients)
  • Specialist involvement or consultation documented in medical records

Submission Process

  1. Provider portal submission through UnitedHealthcare's online system
  2. Phone option: Call 800-711-4555 for urgent cases
  3. Fax backup: 844-403-1027 (verify current number with provider services)
  4. Documentation upload including all diagnostic reports and clinical notes

Avoid These Costly Mistakes

Mistake 1: Incomplete Diagnostic Documentation

The Problem: Submitting PA requests without definitive LAL enzyme testing results or genetic confirmation.

The Fix: Ensure your enzyme activity test shows clear deficiency (<1.5 nmol/h/mL) and include the full lab report with methodology and reference ranges.

Mistake 2: Missing Clinical Context

The Problem: Failing to document how LAL-D affects your specific health status.

The Fix: Include records showing hepatosplenomegaly, abnormal liver function tests, lipid abnormalities, or growth issues that demonstrate medical necessity.

Mistake 3: Incorrect Dosing Requests

The Problem: Requesting doses that don't align with FDA-approved labeling based on age and weight.

The Fix: Verify your prescribed dose matches FDA guidelines: 1 mg/kg every 2 weeks for most patients, with potential increases to 3 mg/kg if needed.

Mistake 4: Waiting Too Long to Appeal

The Problem: Missing Georgia's 60-day deadline for external review after internal appeal denial.

The Fix: Mark your calendar immediately when receiving any denial notice and begin gathering appeal documentation.

Mistake 5: Not Using Available Support

The Problem: Trying to navigate the PA and appeals process alone without leveraging available resources.

The Fix: Contact UnitedHealthcare member services, utilize Counterforce Health's expertise in insurance appeals, or reach out to patient advocacy organizations for guidance.

Quick Action Plan: Three Steps to Take Today

Step 1: Gather Your Documentation (Today)

  • Insurance card with member ID and group number
  • LAL enzyme test results showing deficient activity
  • Recent medical records documenting LAL-D symptoms
  • Current prescription with exact dosing and frequency

Step 2: Initiate the Prior Authorization (This Week)

  • Contact your prescribing physician to submit PA through UnitedHealthcare provider portal
  • Request expedited processing if your condition is urgent
  • Get confirmation number and expected decision timeline
  • Set calendar reminders for follow-up

Step 3: Prepare for Potential Appeal (Within 30 Days)

  • Save all correspondence from UnitedHealthcare
  • Bookmark the Georgia Department of Insurance consumer portal
  • Gather additional clinical evidence supporting medical necessity
  • Identify specialists who can provide supporting documentation if needed

Appeals Process in Georgia

If UnitedHealthcare denies your Kanuma prior authorization, Georgia provides strong consumer protections:

Internal Appeal (Required First Step)

  • Timeline: Submit within 180 days of denial notice
  • Decision deadline: UnitedHealthcare has 30 days for standard appeals, 72 hours for urgent cases
  • How to file: Use member portal, call member services, or submit written appeal
  • Required documents: Denial letter, medical records, physician statement supporting medical necessity

External Review (Independent Physician Review)

  • Eligibility: Available after internal appeal denial
  • Filing deadline: 60 days from internal appeal denial notice
  • Cost: Free to consumers
  • Process: Georgia DOI assigns Independent Review Organization (IRO)
  • Timeline: 45 days for standard review, 72 hours for urgent cases
  • Decision: Binding on UnitedHealthcare if overturned

How to File External Review

  1. Submit request via Georgia DOI online portal
  2. Include documentation: Internal appeal denial, medical records, physician support
  3. Track status: DOI confirms receipt within 3 business days
  4. Await decision: IRO issues binding determination
From our advocates: We've seen many Kanuma denials overturned at the external review level when patients included comprehensive enzyme testing results and detailed clinical documentation showing how LAL-D specifically impacts their health status. The key is demonstrating clear medical necessity with objective evidence.

Resources and Support

UnitedHealthcare Contacts

  • Member Services: 1-800-464-4000
  • Provider Portal: UHCProvider.com (for physicians)
  • Prior Authorization Status: Available through member portal or phone

Georgia State Resources

Clinical Support

Patient Advocacy

  • Counterforce Health: counterforcehealth.org - Specialized insurance appeal support
  • Georgians for a Healthy Future: Consumer assistance with health insurance appeals
  • Georgia Legal Services Program: Free legal aid for Medicaid appeals

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance policies and state regulations may change. Always verify current requirements with your insurer and consult healthcare professionals for medical decisions. For the most current Georgia insurance regulations, visit the Georgia Department of Insurance website.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.